Biotechnology: Biological Products (No Diagnostic Substances)

Corporate ActionJun 25, 2026, 04:16 PM

Eikon Therapeutics to Join Russell 3000 Index

AI Summary

Eikon Therapeutics, Inc. announced its upcoming inclusion in the broad-market Russell 3000® Index, effective after the US market closes on June 26, 2026. The Russell 3000 Index tracks approximately 3,000 stocks, representing 98% of the investable US equity market. This addition is expected to enhance the company's visibility among institutional investors.

Key Highlights

Eikon Therapeutics to be added to the Russell 3000® Index.
Inclusion effective after the US market closes on June 26, 2026.
The Russell 3000 Index measures performance of approximately 3,000 stocks.
It represents 98% of the investable US equity market.
The index is fully reconstituted annually in June.

View SEC Filing

EIKN

Biotechnology: Biological Products (No Diagnostic Substances)

Eikon Therapeutics, Inc.

Price Impact